donepezil has been researched along with ginsenoside rk1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Li, A; Li, L; Liang, G; Ren, J; She, L; Sun, J; Wang, W; Wu, H; Xiong, L; Zhao, X | 1 |
1 other study(ies) available for donepezil and ginsenoside rk1
Article | Year |
---|---|
Ginsenoside RK1 improves cognitive impairments and pathological changes in Alzheimer's disease via stimulation of the AMPK/Nrf2 signaling pathway.
Topics: Alzheimer Disease; AMP-Activated Protein Kinases; Animals; Cognitive Dysfunction; Donepezil; NF-E2-Related Factor 2; Oxidative Stress; Rats; Reactive Oxygen Species; Signal Transduction | 2024 |